PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Hardcore Obstacles to Europe’s HTA Ambitions

Trump and Pharma: Connecting the Dots for an Enraged Media

From Chaos to Calm: Making Sense of Social Media

Advertisement
Interview
Market Access 2017: Mel Formica, Takeda
Pharm Exec talks to Mel Formica, Takeda’s Vice President of Global Market Access, about what he sees as the challenges and opportunities in 2017, and how he envisions the industries market access capabilities evolving
/Read more/
Advertisement
E-Book: A High-Touch Approach to Product Access – Read it Today!
The commercial success of bringing a new pharmaceutical to market begins with the patient. Knowledge of the patient experience combined with therapeutic area expertise helps anticipate challenges in the treatment journey.
Explore how taking a high-touch approach to commercialization can improve product access. Learn more
Interview
Market Access 2017: A European Perspective
Pharm Exec speaks to ICON's Ramita Tandon about how the UK and European regulators' market access plans for 2017 will affect the industry
/Read more/
Advertisement
Pharmaceutical Executive Subscribers Get 20% Off Cold Chain Summit - Canada
The 15th Cold Chain Summit - Canada is returning to Toronto, Feb 27 – March 2. The 2017 event will have the latest information on Health Canada 0069, international GDP requirements, USP initiatives, GS1 Canada updates & more. Learn more
Viewpoint
Partnering for Holistic Solutions
As the healthcare landscape evolves, pharmaceutical companies are being driven to embrace new, unique partnerships to go beyond the pill, writes Weng Si Ho
/Read more/
Advertisement
Regenerative medicine: Overcoming obstacles to reimbursement and market access
Live Webinar: Wednesday, March 8 at 3:00pm EST
Register now
Forecast
Pharm Exec’s Industry Outlook 2017
The populist-driven shifts trumpeted from the US to the EU leaves plenty of question marks when trying to size up the trajectory of the global pharma industry. One certainty, however, will be change
/Read more/
Advertisement
Biologics Manufacturing – Is Your Company Ready?
Live Webinar: Thursday, February 16 at 11:00am EST
Register now
Calendar
/ March 29–31, 2017: DIA EuroMeeting 2017 /
Glasgow, UK
/ February 08–09, 2017: Speaker Programs 2017 /
Philadelphia, PA
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
WASHINGTON, DC
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Advertisement
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
Live Webinar: Tuesday, February 7 at 11:00am EST
Register now
Industry update
//Thomas Smith, M.D. joined Charleston Laboratories (Jupiter, FL) as Chief Medical Officer. Terrence Terifay joined as Chief Commercial Officer.//Shire appointed Ian Clark as a Non-Executive Director.//Healthcare M&A advisory firm VERTESS (Tucson, AZ) appointed Teresa Gonzalo a Managing Director. //Achaogen (South San Francisco, CA) appointed Halley Gilbert, Senior Vice President and Chief Legal Officer of Ironwood Pharmaceuticals, to its Board of Directors.//
Advertisement
From Big Data to Measurable Outcomes: Success with Value-Based Contracts
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com